Mainz BioMed N.V. | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 02/21/2024 at 14:01, 9 months ago

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Mainz Biomed partners with TomaLab to expand ColoAlert® availability in Italy, enhancing colorectal cancer screening. Collaboration brings advanced DNA technology for early detection to Italian healthcare

Italy Mainz Biomed Colorectal Cancer TomaLab ColoAlert®
BRIEF

published on 02/21/2024 at 14:01, 9 months ago

Mainz Biomed announces a strategic partnership in Italy for ColoAlert®

Italy ColoAlert Mainz Biomed Colorectal Cancer Early Screening
PRESS RELEASE

published on 02/06/2024 at 14:01, 9 months 15 days ago

MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY
Mainz Biomed N.V. (NASDAQ:MYNZ) has established the 'European Oncology Lab' (EOL), a physician-led laboratory for expanding service offering to privately insured patients in Germany. The lab will offer ColoAlert® as a laboratory medical service directly to physicians and patients, addressing the crucial requirement for invoicing private health insurance companies

Germany Mainz Biomed N.V. European Oncology Lab ColoAlert Privately Insured Patients
PRESS RELEASE

published on 11/09/2023 at 14:01, 1 year ago

Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
PRESS RELEASE

published on 11/07/2023 at 14:01, 1 year ago

Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
PRESS RELEASE

published on 10/31/2023 at 13:01, 1 year ago

Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
PRESS RELEASE

published on 10/26/2023 at 14:01, 1 year ago

Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
PRESS RELEASE

published on 10/18/2023 at 14:01, 1 year 1 month ago

Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
PRESS RELEASE

published on 10/11/2023 at 14:01, 1 year 1 month ago

Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
PRESS RELEASE

published on 10/05/2023 at 14:01, 1 year 1 month ago

Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit

Accesswire

Published on 11/22/2024 at 00:00, 4 hours 42 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 6 hours 37 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 6 hours 52 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 8 hours 27 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 8 hours 32 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 9 hours 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 10 hours 6 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 10 hours 44 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 10 hours 50 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 10 hours 51 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 21 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 9 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 10 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 10 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 20 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE